To gain insight into the underlying mechanisms by which Zbtb18 regulated hepatic fatty acid metabolism and inflammation, we analyzed the overlapping DEGs identified from the Zbtb18 overexpressing MPHs and the liver from the NAFLD patients. This evidence concerns the gene ZBTB18 and metabolic dysfunction-associated steatotic liver disease.